Home / 6709.TWO : TWO

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does 6709.TWO make money? Does 6709.TWO have pricing power? What's the Earnings Whisper? Will 6709.TWO profit more as the business scales? What is 6709.TWO's management track record? Is 6709.TWO's current price justified?

Advagene Biopharma Co., Ltd.

TWD 24.65 -$3.40 (-12.12%)

TWO · 16 Sep 2026 03:10 UTC

Previous Close

TWD 24.45

Day Range

TWD 24.65 - TWD 24.65

Year Range

TWD 22.5TWD 41

Market Cap

1.69B

AVG Volume

69.53K

Trailing/Forward PE

-16.32/-

PEG ratio

0.62

Dividend Yield

Next Earnings Date

Primary Exchange

Taipei Exchange

Net Income (TWD)

6709.TWO Net Income (TWD) by quarter
Period	Net Income (TWD)
26 Q2	-55.84M
25 Q4	-35.2M
25 Q2	-33.09M
24 Q4	-38.01M
24 Q2	-31.41M
23 Q4	-45.48M
23 Q2	-46.63M
22 Q4	-62.4M
22 Q2	-55.98M
21 Q4	-46.34M

Operating Income (TWD)

6709.TWO Operating Income (TWD) by quarter
Period	Operating Income (TWD)
26 Q2	-56.57M
25 Q4	-36.38M
25 Q2	-34.54M
24 Q4	-38.7M
24 Q2	-32.13K
23 Q4	-45.94M
23 Q2	-47.4K
22 Q4	-63.17K
22 Q2	-118.23M
21 Q4	-46.28M

EBITDA (TWD)

6709.TWO EBITDA (TWD) by quarter
Period	EBITDA (TWD)
26 Q2	-53.12M
25 Q4	-35.28M
25 Q2	-34.4M
24 Q4	-36.81M
24 Q2	-30.28M
23 Q4	-44.09K
23 Q2	-45.22K
22 Q4	-60.92K
22 Q2	-106.63M
21 Q4	-42.42M

Cash Flows (TWD)

6709.TWO Cash Flows (TWD) by quarter
Period	Cash Flows (TWD)
26 Q2	-57.96M
25 Q4	-32.61M
25 Q2	-32.83K
24 Q4	-43.28K
24 Q2	-26.91K
23 Q4	-37.92K
23 Q2	-39.78K
22 Q4	-55.41K
21 Q4	-33.85M
21 Q2	-33.85M

EPS (TWD)

6709.TWO EPS (TWD) by quarter
Period	EPS (TWD)
26 Q2	-0.92
25 Q4	-0.59
25 Q2	-0.56
24 Q4	-0.68
24 Q2	-0
23 Q4	-0.88
23 Q2	-0.94
22 Q4	-1.26
22 Q2	-1.14
21 Q4	-0.94

Expenses (TWD)

6709.TWO Expenses (TWD) by quarter
Period	Expenses (TWD)
21 Q2	260.5K
26 Q2	53.65M
25 Q4	37.45M
25 Q2	34.54M
24 Q4	37.6M
24 Q2	32.16K
23 Q4	45.46K
23 Q2	47.88K
22 Q4	63.38K
22 Q2	119.75M
21 Q4	47.47M

Cash & Debt (TWD)

6709.TWO Cash & Debt (TWD) by quarter
Period	Cash & Debt (TWD)
26 Q2	325.18M
25 Q4	134.83M
25 Q2	167.68M
24 Q4	202.32M
24 Q2	96.53M
23 Q4	125.19M
23 Q2	61.41M
22 Q4	103.01M
21 Q4	223.83M
21 Q2	248.66M

Debt ratios

6709.TWO Debt ratios by quarter
Period	Debt ratios
26 Q2	2.01
25 Q4	0.96
25 Q2	1.6
24 Q4	2.91
24 Q2	2.93
23 Q4	1.16
23 Q2	0.4
22 Q4	0.52
21 Q4	1.49
21 Q2	1.6

Return on Capital

6709.TWO Return on Capital by quarter
Period	Return on Capital
26 Q2	-15.67%
25 Q4	-23.12%
25 Q2	-17.65%
24 Q4	-17.24%
24 Q2	-28.93%
23 Q4	-32.5%
23 Q2	-54.77%
22 Q4	-47.36%
21 Q4	-18.57%
21 Q2	-16.89%

Shares Outstanding

6709.TWO Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	60.73M
25 Q4	59.38M
25 Q2	59.38M
24 Q4	55.76M
24 Q2	53.38M
23 Q4	51.43M
23 Q2	49.35M
22 Q4	49.35M
22 Q2	49.35M
21 Q4	49.18M

Book Value Per Share (TWD)

6709.TWO Book Value Per Share (TWD) by quarter
Period	Book Value Per Share (TWD)
26 Q2	5.87
25 Q4	2.56
25 Q2	3.16
24 Q4	3.95
24 Q2	2.03
23 Q4	2.72
23 Q2	1.73
22 Q4	2.67
21 Q4	5.07
21 Q2	5.58

Total Assets (TWD)

6709.TWO Total Assets (TWD) by quarter
Period	Total Assets (TWD)
26 Q2	366.03M
25 Q4	166.51M
25 Q2	197.26M
24 Q4	232.21M
24 Q2	126.5M
23 Q4	147.93M
23 Q2	93.9M
22 Q4	140.84M
21 Q4	260.41M
21 Q2	288.33M

Free Cash Flow Yield

6709.TWO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-2.25%
Sep 26	-2.24%
Sep 26	-2.25%
Aug 26	-2.17%
Aug 26	-2.19%
Aug 26	-2.21%
Aug 26	-2.13%
Jul 26	-2.35%
Jul 26	-2.21%
Jul 26	-2.35%
Jul 26	-2.18%
Jul 26	-2.19%
Jun 26	-2.28%
Jun 26	-2.19%
Jun 26	-2.2%
Jun 26	-2.19%
May 26	-2.14%
May 26	-2.04%
May 26	-2.2%
May 26	-2.17%
Apr 26	-2.11%
Apr 26	-2.12%
Apr 26	-2.13%
Apr 26	-2.04%
Apr 26	-2.05%
Mar 26	-0.01%
Mar 26	-0.01%
Mar 26	-0.01%
Mar 26	-0.01%
Feb 26	-0.01%
Feb 26	-0.01%
Feb 26	-0.01%
Jan 26	-0.01%
Jan 26	-0.01%
Jan 26	-0.01%
Jan 26	-0.01%
Jan 26	-0.01%
Dec 25	-0.01%
Dec 25	-0.01%
Dec 25	-0.01%
Dec 25	-0.01%
Nov 25	-0.01%
Nov 25	-0.01%
Nov 25	-0.01%
Nov 25	-0.01%
Oct 25	-0.01%
Oct 25	-0.01%
Oct 25	-0.01%
Oct 25	-0.01%
Oct 25	-0.01%
Sep 25	-0.01%
Sep 25	-0.01%
Sep 25	-0.01%
Sep 25	-0.01%
Aug 25	-0.01%
Aug 25	-0.01%
Aug 25	-0.01%
Aug 25	-0.01%
Aug 25	-0.01%
Jul 25	-0.01%
Jul 25	-0.01%
Jul 25	-0.01%
Jul 25	-0.01%
Jun 25	-0.01%
Jun 25	-0.01%
Jun 25	-0.01%
Jun 25	-0.01%
May 25	-0.02%
May 25	-0.02%
May 25	-0.02%
May 25	-0.02%
May 25	-0.02%
Apr 25	-0.02%
Apr 25	-0.02%
Apr 25	-0.01%
Apr 25	-0.01%
Mar 25	-0.01%
Mar 25	-0.01%
Mar 25	-0.01%
Mar 25	-0.01%
Feb 25	-0.01%
Feb 25	-0.02%
Feb 25	-0.02%
Feb 25	-0.01%
Jan 25	-0.01%
Jan 25	-0.01%
Jan 25	-0.01%
Jan 25	-0.01%
Dec 24	-0.01%
Dec 24	-0.02%
Dec 24	-0.01%
Dec 24	-0.02%
Nov 24	-0.02%
Nov 24	-0.02%
Nov 24	-0.01%
Nov 24	-0.01%
Nov 24	-0.01%
Oct 24	-0.01%
Oct 24	-0.01%
Oct 24	-0.01%

Price to Book

6709.TWO Price to Book by quarter
Period	Price to Book
Sep 26	9.54
Sep 26	9.57
Sep 26	9.56
Aug 26	9.91
Aug 26	9.81
Aug 26	9.71
Aug 26	10.1
Jul 26	9.13
Jul 26	9.71
Jul 26	9.15
Jul 26	9.87
Jul 26	9.81
Jun 26	9.44
Jun 26	9.79
Jun 26	9.75
Jun 26	9.83
May 26	10.06
May 26	10.53
May 26	9.77
May 26	9.91
Apr 26	10.18
Apr 26	10.14
Apr 26	10.08
Apr 26	10.55
Apr 26	10.48
Mar 26	9.05
Mar 26	9.5
Mar 26	9.76
Mar 26	9.74
Feb 26	10.53
Feb 26	10.06
Feb 26	10.49
Jan 26	10.55
Jan 26	8.98
Jan 26	8.27
Jan 26	8.49
Jan 26	8.74
Dec 25	8.87
Dec 25	8.9
Dec 25	9.47
Dec 25	9.58
Nov 25	9.74
Nov 25	8.62
Nov 25	9.52
Nov 25	10.44
Oct 25	10.34
Oct 25	11.39
Oct 25	11.45
Oct 25	11.66
Oct 25	11.45
Sep 25	8.63
Sep 25	8.32
Sep 25	7.61
Sep 25	5.8
Aug 25	5.78
Aug 25	5.59
Aug 25	5.54
Aug 25	5.61
Aug 25	5.39
Jul 25	5.04
Jul 25	5.15
Jul 25	5.34
Jul 25	5.49
Jun 25	5.21
Jun 25	4.85
Jun 25	5.64
Jun 25	4.56
May 25	4.3
May 25	4.26
May 25	4.37
May 25	4.4
May 25	4.34
Apr 25	4.35
Apr 25	4.21
Apr 25	4.49
Apr 25	5.31
Mar 25	10.52
Mar 25	10.77
Mar 25	11.31
Mar 25	11.78
Feb 25	12.96
Feb 25	9.74
Feb 25	9.49
Feb 25	10.08
Jan 25	10.25
Jan 25	10.03
Jan 25	10.18
Jan 25	10.35
Dec 24	10.18
Dec 24	9.34
Dec 24	10.06
Dec 24	9.17
Nov 24	9.71
Nov 24	9.74
Nov 24	10.35
Nov 24	11.06
Nov 24	11.6
Oct 24	12.05
Oct 24	11.8
Oct 24	11.78

No video analysis for this stock yet. Request one from our team.

AI Analysis

Advagene Biopharma Co., Ltd.

Video analysis: 6709.TWO

Similar companies